Tweet
Source: https://www.reuters.com/world/us/few...ys-2022-08-09/
Few U.S. patients with hepatitis C get timely treatment, CDC says
By Mrinalika Roy
August 9, 20221:53 PM EDTLast Updated 4 hours ago
Aug 9 (Reuters) - Few U.S. adults diagnosed with hepatitis C virus infections receive timely treatment with antiviral drugs, the U.S. Centers for Disease Control and Prevention said on Tuesday.
The drugs cure hepatitis C in more than 95% of patients, but a study of more than 47,000 adults diagnosed in 2019 or 2020 found that only one-third of those with private insurance and one-quarter of Medicaid and Medicare recipients got one of these drugs within a year, according to a report in the CDC's Vital Signs.
Treatment rates were lowest among patients in state-administered health plans, with only 23% of Medicaid recipients and 28% of Medicare recipients receiving the drugs within a year of diagnosis, the study showed. That rate was only 35% among patients with private insurance.
Lower odds of treatment were also seen in states with Medicaid restrictions and in non-white patients...
Few U.S. patients with hepatitis C get timely treatment, CDC says
By Mrinalika Roy
August 9, 20221:53 PM EDTLast Updated 4 hours ago
Aug 9 (Reuters) - Few U.S. adults diagnosed with hepatitis C virus infections receive timely treatment with antiviral drugs, the U.S. Centers for Disease Control and Prevention said on Tuesday.
The drugs cure hepatitis C in more than 95% of patients, but a study of more than 47,000 adults diagnosed in 2019 or 2020 found that only one-third of those with private insurance and one-quarter of Medicaid and Medicare recipients got one of these drugs within a year, according to a report in the CDC's Vital Signs.
Treatment rates were lowest among patients in state-administered health plans, with only 23% of Medicaid recipients and 28% of Medicare recipients receiving the drugs within a year of diagnosis, the study showed. That rate was only 35% among patients with private insurance.
Lower odds of treatment were also seen in states with Medicaid restrictions and in non-white patients...
Comment